Funded Tech Companies
Oblenio Bio
Wondering who provided funding to Oblenio Bio? Aditum Bio, Pfizer Venture Investments and GV joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Oblenio Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4 Maguire Road
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Oblenio Bio aims to transform the treatment of refractory autoimmune diseases, putting the promise of immune reset in reach for millions of patients. Oblenio Bio is pursuing broad immune reset as a transformative therapy for refractory autoimmune diseases through our LBL-051 T-cell engager.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/25/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samantha Truex
Chief Medical Officer
Tapan Maniar
Chief Operating Officer
Laurie Berggren
Vice President
Sara Burke
VP - Bus. Development
Rohan Lathia
VP - Engineering
Tara Barreira
VP - Operations
Christine Cornwell
Company Investors
- Aditum Bio
- Pfizer Venture Investments
- GV
- Deep Track Capital
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs